Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 80335, 80336, 80337

Official Description

Doxepin

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 80166 refers to a laboratory test specifically designed to measure the levels of doxepin in the blood. Doxepin, which is also known by its brand name Sinequan, is classified as a tricyclic antidepressant. It is primarily utilized in the treatment of various mental health conditions, including depression and anxiety disorders. The test is crucial for monitoring the therapeutic levels of doxepin, which are defined as being between 100 to 300 ng/ml. Levels exceeding 500 ng/ml are considered toxic and may lead to adverse effects. Symptoms associated with doxepin toxicity can manifest as anticholinergic effects, which include flushing, dry skin, dry mucous membranes, urinary retention, and an increased heart rate, known as tachycardia. To accurately assess doxepin levels, a blood sample is collected through a procedure known as venipuncture, which is separately reportable. It is important that the blood draw occurs prior to the administration of the drug to ensure that the measurement reflects the trough level of doxepin. The analysis of the serum or plasma is conducted using a sophisticated technique called quantitative liquid chromatography-tandem mass spectrometry, which allows for precise quantification of the drug in the sample.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The laboratory test for doxepin levels is indicated for the following conditions:

  • Monitoring Therapeutic Levels This test is performed to ensure that the doxepin levels remain within the therapeutic range of 100-300 ng/ml, which is essential for effective treatment of depression and anxiety.
  • Assessing Toxicity The test is also indicated when there is a suspicion of doxepin toxicity, particularly when levels exceed 500 ng/ml, to prevent or manage potential adverse effects.
  • Evaluating Patient Compliance It may be used to assess whether patients are adhering to their prescribed doxepin regimen, as inconsistent levels may indicate non-compliance.

2. Procedure

The procedure for obtaining doxepin levels involves several critical steps to ensure accurate results:

  • Step 1: Patient Preparation Prior to the blood draw, the patient should be informed about the procedure and the importance of having the blood sample taken before any doxepin administration. This ensures that the sample reflects the trough level of the medication.
  • Step 2: Venipuncture A qualified healthcare professional will perform venipuncture, which involves inserting a needle into a vein, typically in the arm, to collect a blood sample. This step is crucial as it is separately reportable and must be done with care to minimize discomfort and ensure sample integrity.
  • Step 3: Sample Handling Once the blood sample is collected, it should be properly labeled and handled according to laboratory protocols to prevent contamination or degradation of the sample.
  • Step 4: Laboratory Analysis The collected serum or plasma is then subjected to quantitative liquid chromatography-tandem mass spectrometry. This advanced analytical technique allows for precise measurement of doxepin levels in the sample, providing accurate results for clinical interpretation.

3. Post-Procedure

After the blood sample has been collected, there are a few considerations for post-procedure care. The site of venipuncture may experience some minor discomfort or bruising, which typically resolves on its own. Patients are generally advised to apply pressure to the site to minimize bleeding and to keep the area clean. Results from the doxepin level test will be analyzed and reported back to the healthcare provider, who will interpret the findings in the context of the patient's treatment plan. If toxic levels are detected, appropriate clinical interventions may be necessary to address the potential side effects associated with elevated doxepin levels.

Short Descr ASSAY OF DOXEPIN
Medium Descr DRUG SCREEN QUANTITATIVE DOXEPIN
Long Descr Doxepin
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 9 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 235 - Other Laboratory
Date
Action
Notes
2015-01-01 Deleted Code deleted, see 80335, 80336, 80337
2013-01-01 Changed Medium description changed per AMA 2013 corrections document dated January 25, 2013.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"